Abbott Laboratories : ABT

All Abbott Laboratories Articles

321 Articles

Eric Bleeker | Jul 17, 2025 at 6:45 AM EDT

Live: Abbott Labs (NYSE: ABT) Sinks 6% After Releasing Q2 Earnings

Abbott Laboratories (NYSE: ABT | ABT Price Prediction) is reporting before the market opens and we’ll be updating this article…

Lee Jackson | Jun 13, 2025 at 6:43 AM EDT

5 Dividend Kings Are Delivering Massive Total Returns of Up to 34% This Year

These five top Dividend Kings have posted massive double-digit total return figures so far this year and are Buy-rated by…

Lee Jackson | May 23, 2025 at 7:41 AM EDT

4 Dividend Aristocrats Are Absolutely Crushing the S&P 500 in 2025

These four Dividend Aristocrats are far outperforming the S&P 500 so far this year. They still offer investors good entry…

Lee Jackson | May 20, 2025 at 1:14 PM EDT

Stifel Has Big Second-Half Stock Market Concerns: 5 Defensive Value Dividend Stocks Buys

Stifel recommends “defensive value” stocks for the remainder of 2025, and the firm has these five rated Buy.

Gerelyn Terzo | Apr 16, 2025 at 10:55 AM EDT

S&P 500 (NYSEARCA: SPY) Live: JBHT (Nasdaq: JBHT) Falls, ABT (NYSE: ABT) Rises on Tariff Fallout

The markets remain stuck in the doldrums, owing to tariffs, but appear to be coming off their lows of the…

Trey Thoelcke | Nov 16, 2024 at 9:10 AM EST

Dividend King AbbVie Just Paid Investors: Here’s How Much They Got

AbbVie has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady…

Rich Duprey | Aug 27, 2024 at 10:19 AM EDT

2 Stocks to Buy Now Before a Stock Market Crash

A recession is looming. Despite the S&P 500 nearing its all-time high, the yield curve inverted and the Sahm Rule…

Rich Duprey | Aug 27, 2024 at 9:26 AM EDT

Can These 3 Nasdaq 100 Laggards Rebound in September?

Investors have been on a roller coaster ride for the past four years and the stock market may be heading…

Lee Jackson | Aug 13, 2024 at 10:08 AM EDT

Prediction: Abbvie’s Dividend Payouts Will Increase in 2025

24/7 Wall St. Insights Stocks that consistently raise their dividends offer investors huge total return potential. Dividend stocks will become…

Lee Jackson | May 11, 2024 at 8:53 AM EDT

JP Morgan Has 5 Blue Chip Passive Income Stocks as Top Picks for May

24/7 Insights AI stocks are facing headwinds and sky high valuations are cooling down J.P. Morgan’s top picks are in…

Trey Thoelcke | Jan 26, 2024 at 9:49 AM EST

How Safe Is AbbVie Stock’s 3.7% Dividend?

Here is an assessment of how safe the dividend at AbbVie appears to be based on a variety of metrics,…

Trey Thoelcke | Jan 25, 2024 at 11:48 AM EST

Just How Safe Is Abbott Labs Stock’s Dividend?

Here is an assessment of how safe the dividend at Abbott Laboratories appears to be based on a variety of…

Lee Jackson | Sep 7, 2023 at 7:10 AM EDT

8 Dividend Aristocrat Stocks to Buy Now With a Recession (and Inflation) Looming Large in 2024

These eight top Dividend Aristocrats pay among the biggest dividends in the sectors that typically do well during a recession.…

Lee Jackson | May 31, 2023 at 8:54 AM EDT

Wednesday’s Top Analyst Upgrades and Downgrades: Abbott Labs, Boston Scientific, ChargePoint, Coinbase, Dollar General, Equitrans, Ford, Hasbro, Johnson & Johnson, Kenvue, Medtronic and More

Wednesday's top analyst upgrades and downgrades included Abbott Laboratories, Boston Scientific, ChargePoint, Coinbase Global, Dollar General, Equitrans Midstream, Ford, Hasbro,…

Paul Ausick | Apr 17, 2023 at 11:15 AM EDT

Earnings Previews: Abbott Labs, ASML, Baker Hughes, Morgan Stanley

Before U.S. markets open on Wednesday, these four companies are set to report quarterly earnings.

1 2 3 4 5 … 22

Abbott Laboratories : ABT

All Abbott Laboratories Articles

Live: Abbott Labs (NYSE: ABT) Sinks 6% After Releasing Q2 Earnings

5 Dividend Kings Are Delivering Massive Total Returns of Up to 34% This Year

4 Dividend Aristocrats Are Absolutely Crushing the S&P 500 in 2025

Stifel Has Big Second-Half Stock Market Concerns: 5 Defensive Value Dividend Stocks Buys

S&P 500 (NYSEARCA: SPY) Live: JBHT (Nasdaq: JBHT) Falls, ABT (NYSE: ABT) Rises on Tariff Fallout

Dividend King AbbVie Just Paid Investors: Here’s How Much They Got

2 Stocks to Buy Now Before a Stock Market Crash

Can These 3 Nasdaq 100 Laggards Rebound in September?

Prediction: Abbvie’s Dividend Payouts Will Increase in 2025

JP Morgan Has 5 Blue Chip Passive Income Stocks as Top Picks for May

How Safe Is AbbVie Stock’s 3.7% Dividend?

Just How Safe Is Abbott Labs Stock’s Dividend?

8 Dividend Aristocrat Stocks to Buy Now With a Recession (and Inflation) Looming Large in 2024

Wednesday’s Top Analyst Upgrades and Downgrades: Abbott Labs, Boston Scientific, ChargePoint, Coinbase, Dollar General, Equitrans, Ford, Hasbro, Johnson & Johnson, Kenvue, Medtronic and More

Earnings Previews: Abbott Labs, ASML, Baker Hughes, Morgan Stanley

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

ISPY’s 0.56% Fee Hides a $38,000 Decade-Long Performance Gap Against SPY

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

Abbott Laboratories : ABT

All Abbott Laboratories Articles

Live: Abbott Labs (NYSE: ABT) Sinks 6% After Releasing Q2 Earnings

5 Dividend Kings Are Delivering Massive Total Returns of Up to 34% This Year

4 Dividend Aristocrats Are Absolutely Crushing the S&P 500 in 2025

Stifel Has Big Second-Half Stock Market Concerns: 5 Defensive Value Dividend Stocks Buys

S&P 500 (NYSEARCA: SPY) Live: JBHT (Nasdaq: JBHT) Falls, ABT (NYSE: ABT) Rises on Tariff Fallout

Dividend King AbbVie Just Paid Investors: Here’s How Much They Got

2 Stocks to Buy Now Before a Stock Market Crash

Can These 3 Nasdaq 100 Laggards Rebound in September?

Prediction: Abbvie’s Dividend Payouts Will Increase in 2025

JP Morgan Has 5 Blue Chip Passive Income Stocks as Top Picks for May

How Safe Is AbbVie Stock’s 3.7% Dividend?

Just How Safe Is Abbott Labs Stock’s Dividend?

8 Dividend Aristocrat Stocks to Buy Now With a Recession (and Inflation) Looming Large in 2024

Wednesday’s Top Analyst Upgrades and Downgrades: Abbott Labs, Boston Scientific, ChargePoint, Coinbase, Dollar General, Equitrans, Ford, Hasbro, Johnson & Johnson, Kenvue, Medtronic and More

Earnings Previews: Abbott Labs, ASML, Baker Hughes, Morgan Stanley

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

ISPY’s 0.56% Fee Hides a $38,000 Decade-Long Performance Gap Against SPY

Featured Reads

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income